Maria A. Velez

Oncology

100 Medical Plz Ste 550
Los Angeles, CA 90095

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Evaluating datopotamab deruxtecan (Dato-DXd) as a novel treatment option for EGFR-mutated non-small cell lung cancer.

Evaluating datopotamab deruxtecan (Dato-DXd) as a novel treatment option for EGFR-mutated non-small cell lung cancer.

Journal: Future oncology (London, England)

Published: June 25, 2026

Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1.

Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1.

Journal: JCEM case reports

Published: January 13, 2026

Differences in Clinical Trial Availability vs Distribution of Disease Among Gynecological Cancers.

Differences in Clinical Trial Availability vs Distribution of Disease Among Gynecological Cancers.

Journal: Oncology (Williston Park, N.Y.)

Published: December 10, 2025

Identification of Targetable EGFR Mutations in Ovarian Cancer.

Identification of Targetable EGFR Mutations in Ovarian Cancer.

Journal: JCO precision oncology

Published: September 10, 2025

Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring After Therapy.

Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring After Therapy.

Journal: JCO oncology practice

Published: June 02, 2025

Expanding Lung Cancer Clinical Trial Criteria: A Systematic Review on Inclusion of Patients with Brain Metastases and Leptomeningeal Disease.

Expanding Lung Cancer Clinical Trial Criteria: A Systematic Review on Inclusion of Patients with Brain Metastases and Leptomeningeal Disease.

Journal: Clinical lung cancer

Published: May 30, 2025

Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer.

Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer.

Journal: Chest

Published: March 10, 2025

A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol.

A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol.

Journal: BMC cancer

Published: August 28, 2024

Characteristics of clinical trials associated with appeal and return on investment to participants: a review and framework.

Characteristics of clinical trials associated with appeal and return on investment to participants: a review and framework.

Journal: The oncologist

Published: July 31, 2024

Consent document translation expense hinders inclusive clinical trial enrolment.

Consent document translation expense hinders inclusive clinical trial enrolment.

Journal: Nature

Published: December 14, 2022

Is There a Place for Temozolomide plus Nivolumab among Neuroendocrine Neoplasms?

Is There a Place for Temozolomide plus Nivolumab among Neuroendocrine Neoplasms?

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 05, 2022

What is the current role of immunotherapy in EGFR mutant advanced NSCLC?

What is the current role of immunotherapy in EGFR mutant advanced NSCLC?

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 23, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026